trending Market Intelligence /marketintelligence/en/news-insights/trending/4ya7ciak1jcdbfj-htiqyw2 content esgSubNav
In This List

Retrophin CEO plans to retire

Blog

Insight Weekly: M&A players predict 2023 activity; SPAC IPOs dip; 2022 capacity retirements up

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share


Retrophin CEO plans to retire

Retrophin Inc. said Stephen Aselage plans to retire as CEO.

Aselage, who has been CEO since November 2014, will step down after the company identifies his successor.

Retrophin's board has initiated a global search for his successor that will include both internal and external candidates.

San Diego, Calif.-based Retrophin develops treatments for serious or rare diseases. Martin Shkreli, who was convicted of securities fraud in March, is the company's co-founder and former CEO.